7-((methylethoxyphosphinyl)oxy)-1-methylquinolinium has been researched along with pralidoxime in 1 studies
| Studies (7-((methylethoxyphosphinyl)oxy)-1-methylquinolinium) | Trials (7-((methylethoxyphosphinyl)oxy)-1-methylquinolinium) | Recent Studies (post-2010) (7-((methylethoxyphosphinyl)oxy)-1-methylquinolinium) | Studies (pralidoxime) | Trials (pralidoxime) | Recent Studies (post-2010) (pralidoxime) |
|---|---|---|---|---|---|
| 12 | 0 | 0 | 658 | 28 | 156 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashani, Y; Levy, D | 1 |
1 other study(ies) available for 7-((methylethoxyphosphinyl)oxy)-1-methylquinolinium and pralidoxime
| Article | Year |
|---|---|
Synthesis and in vitro properties of a powerful quaternary methylphosphonate inhibitor of acetylcholinesterase. A new marker in blood-brain barrier research.
Topics: Acetylcholinesterase; Animals; Blood-Brain Barrier; Brain; Butyrylcholinesterase; Cholinesterase Inhibitors; Eels; Horses; Isomerism; Kinetics; Magnetic Resonance Spectroscopy; Mathematics; Mice; Pralidoxime Compounds; Quinolinium Compounds | 1986 |